The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers
- PMID: 1493840
- DOI: 10.1007/BF02284957
The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers
Abstract
We gave 24 healthy elderly volunteers with a perceived sleep onset of at least 30 minutes zolpidem 5 mg, zolpidem 10 mg, or placebo for 7 days in a double-blind, three-way, crossover study. The morning after nocturnal dosing, psychomotor performance and cognitive ability were measured using tests which are sensitive to the residual effects of hypnotics and to the effects of drugs on various indicators of sleep quality. The tests were: Choice Reaction Time; Tracking; Critical Flicker Fusion Threshold; Memory Scanning; Word Recognition; the Leeds Sleep Evaluation Questionnaire and Line Analogue Rating Scales. Zolpidem produced a subjective improvement in sleep but did not impair performance the following day. Furthermore, during repeated administration, there was no tolerance to the effects of sleep latency and quality of sleep, nor adverse effects on task performance.
Similar articles
-
A double-blind, placebo- and flurazepam-controlled investigation of the residual psychomotor and cognitive effects of modified release zolpidem in young healthy volunteers.J Clin Psychopharmacol. 2006 Jun;26(3):284-9. doi: 10.1097/01.jcp.0000218985.07425.d9. J Clin Psychopharmacol. 2006. PMID: 16702893 Clinical Trial.
-
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers.Hum Psychopharmacol. 2008 Dec;23(8):693-705. doi: 10.1002/hup.980. Hum Psychopharmacol. 2008. PMID: 18763235 Clinical Trial.
-
Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.Br J Clin Pharmacol. 1990 Sep;30(3):463-9. doi: 10.1111/j.1365-2125.1990.tb03798.x. Br J Clin Pharmacol. 1990. PMID: 2223425 Free PMC article. Clinical Trial.
-
Assessing the residual effects of hypnotics.Acta Psychiatr Belg. 1994 Mar-Apr;94(2):88-95. Acta Psychiatr Belg. 1994. PMID: 7502663 Review.
-
Psychological performance models as indicators of the effects of hypnotic drugs on sleep.Psychopharmacology Suppl. 1984;1:58-68. doi: 10.1007/978-3-642-69659-6_4. Psychopharmacology Suppl. 1984. PMID: 6382255 Review.
Cited by
-
A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs.Drugs Aging. 2012 Aug 1;29(8):639-58. doi: 10.1007/BF03262280. Drugs Aging. 2012. PMID: 22812538
-
EEG profile of intravenous zolpidem in healthy volunteers.Psychopharmacology (Berl). 1994 Feb;114(1):138-46. doi: 10.1007/BF02245455. Psychopharmacology (Berl). 1994. PMID: 7846196 Clinical Trial.
-
Comparative tolerability of newer agents for insomnia.Drug Saf. 2009;32(9):735-48. doi: 10.2165/11312920-000000000-00000. Drug Saf. 2009. PMID: 19670914 Review.
-
Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?CNS Drugs. 2007;21(5):389-405. doi: 10.2165/00023210-200721050-00003. CNS Drugs. 2007. PMID: 17447827 Review.
-
Association Between the Use of Non-benzodiazepine Hypnotics and Cognitive Outcomes: A Systematic Review.Curr Sleep Med Rep. 2020 Mar;6(1):11-20. doi: 10.1007/s40675-020-00163-1. Epub 2020 Jan 28. Curr Sleep Med Rep. 2020. PMID: 33457189 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources